Evidence map›Paper›PMID 40422357›Full record

ArticleGels (Basel, Switzerland)2025

Ultra-High Dose Rate Electron Beam Dosimetry Using Ag Nanoparticle-Enhanced nPAG and NIBMAGAT Gels.

Mantvydas Merkis, Akvile Slektaite-Kisone, Marius Burkanas, Aleksandras Cicinas, Mindaugas Dziugelis, Vaidas Klimkevicius, Diana Adliene, Jonas Venius

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mantvydas MerkisDepartment of Physics, Kaunas University of Technology, Studentų g. 50, LT-51368 Kaunas, Lithuania.ORCID 0000-0002-2602-8664
Akvile Slektaite-KisoneMedical Physics Department, National Cancer Center, Affiliate of Vilnius University Hospital Santaros Klinikos, Santariškių g. 1, LT-08406 Vilnius, Lithuania.
Marius BurkanasMedical Physics Department, National Cancer Center, Affiliate of Vilnius University Hospital Santaros Klinikos, Santariškių g. 1, LT-08406 Vilnius, Lithuania.
Aleksandras CicinasMedical Physics Department, National Cancer Center, Affiliate of Vilnius University Hospital Santaros Klinikos, Santariškių g. 1, LT-08406 Vilnius, Lithuania.
Mindaugas DziugelisMedical Physics Department, National Cancer Center, Affiliate of Vilnius University Hospital Santaros Klinikos, Santariškių g. 1, LT-08406 Vilnius, Lithuania.
Vaidas KlimkeviciusInstitute of Chemistry, Vilnius University, Naugarduko g. 24, LT-03225 Vilnius, Lithuania.ORCID 0000-0001-9463-4968
Diana AdlieneDepartment of Physics, Kaunas University of Technology, Studentų g. 50, LT-51368 Kaunas, Lithuania.ORCID 0000-0002-8683-8757
Jonas VeniusMedical Physics Department, National Cancer Center, Affiliate of Vilnius University Hospital Santaros Klinikos, Santariškių g. 1, LT-08406 Vilnius, Lithuania.ORCID 0000-0002-9294-3190

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FLASH radiation therapy is an emerging technique that provides several advantages over conventional radiotherapy. By delivering ultra-high dose rate radiation, the damage to healthy tissues surrounding the treatment area is minimized, treatment time is reduced and treatment outcomes of radioresistant tumors are improved. Despite its promising potential, FLASH radiation therapy remains relatively understudied, particularly in the field of dosimetry. Polymer gel dosimetry is a promising technique for verifying FLASH radiation therapy because it enables volumetric dose distribution measurements with high spatial accuracy. This study investigates the applicability of two commonly used polymer gel dosimeters, nPAG and NIBMAGAT, enhanced with nanoparticles, in ultra-high dose rate radiation therapy. The results indicate that NIBMAGAT gel, enriched with Ag nanoparticles, outperforms nPAG. NIBMAGAT gel exhibits less saturation at high doses, maintains dose rate independence and offers comparable sensitivity to nPAG formulation.

Indexed as

FLASHgel dosimetryradiotherapy

Identifiers

PMID40422357
PMCPMC12111760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.